New drug cocktails tested against spreading breast cancer
NCT ID NCT02057133
Summary
This early-stage study is testing the safety of a drug called abemaciclib when combined with various other breast cancer therapies. It involves 198 people whose breast cancer has spread to other parts of the body. The main goal is to see which drug combinations are safe and tolerable, while also checking if they help shrink tumors.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST NEOPLASMS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Columbia University College of Phys & Surgeons
New York, New York, 10032, United States
-
Dana Farber Cancer Institute
Boston, Massachusetts, 02215, United States
-
Highlands Oncology Group - Duplicate 2
Rogers, Arkansas, 72758, United States
-
Mayo Clinic
Rochester, Minnesota, 55905-0002, United States
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
-
Peggy and Charles Stephenson Oklahoma Cancer Center
Nashville, Tennessee, 37203, United States
-
Providence Cancer Center Oncology Hematology Care
Portland, Oregon, 97213, United States
-
South Texas Accelerated Research Therapeutics (START)
San Antonio, Texas, 78229-3307, United States
-
Tennessee Oncology PLLC
Nashville, Tennessee, 37203, United States
-
Univ of Pittsburgh Cancer Inst. (UPCI)
Pittsburgh, Pennsylvania, 15213, United States
-
University of California - San Diego
La Jolla, California, 92037-0845, United States
-
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, 27514, United States
-
Vanderbilt University Medical Center
Nashville, Tennessee, 37232-6307, United States
Conditions
Explore the condition pages connected to this study.